Objective: Progress toward understanding brain mechanisms in psychosis is hampered by failures to account for within-group heterogeneity that exists across neuropsychological domains. We recently identified distinct cognitive subgroups that might assist in identifying more biologically meaningful subtypes of psychosis. In the present study, we examined whether underlying structural brain abnormalities differentiate these cognitively derived subgroups. Method: 1.5T T1 weighted structural scans were acquired for 168 healthy controls and 220 patients with schizophrenia/schizoaffective disorder. Based on previous work, 47 patients were categorized as being cognitively compromised (impaired premorbid and current IQ), 100 as cognitively deteriorated (normal premorbid IQ, impaired current IQ), and 73 as putatively cognitively preserved (premorbid and current IQ within 1 SD of controls). Global, subcortical and cortical volume, thickness, and surface area measures were compared among groups. Results: Whole cortex, subcortical, and regional volume and thickness reductions were evident in all subgroups compared to controls, with the largest effect sizes in the compromised group. This subgroup also showed abnormalities in regions not seen in the other patient groups, including smaller left superior and middle frontal areas, left anterior and inferior temporal areas and right lateral medial and inferior frontal, occipital lobe and superior temporal areas. Conclusions: This pattern of more prominent brain structural abnormalities in the group with the most marked cognitive impairments-both currently and putatively prior to illness onset, is consistent with the concept of schizophrenia as a progressive neurodevelopmental disorder. In this group, neurodevelopmental and neurodegenerative factors may be important for cognitive function.
Schizophrenia is a heterogeneous disorder that varies in its cognitive presentation. Past literature indicates a broad spectrum of cognitive functioning, ranging from intact ability or mild deficits, to severe and profound impairments. 1, 2 Work using different statistical clustering techniques shows that schizophrenia patients can be subgrouped into 2-to-4 more homogeneous clusters on the basis of neuropsychological data tapping predominantly "fluid" cognitive processes. [3] [4] [5] [6] [7] These clusters can be distinguished in terms of the severity of their cognitive impairments and their psychosocial outcomes; with the more severely impaired patients tending to demonstrate evidence of poorer functioning relative to less-impaired groups. 3, 8 Among individuals with schizophrenia with moderateto-severe cognitive deficits in fluid intelligence, there is variability in the extent to which crystallized intelligence is also affected. 4, [7] [8] [9] [10] Crystallized intelligence is generally measured by performance on "hold tests" including vocabulary or word reading, that tap into abilities that require intact functioning during development for adequate performance. As these hold tests are thought to be immune to age-related decline, their use in psychiatric disorders is considered to index the extent of intellectual functioning (premorbid IQ) prior to illness onset. 11, 12 For some patients, impaired current cognition in the context of intact premorbid IQ, suggests a putatively normal early developmental cognitive path followed by a decline in intellectual functioning possibly associated with pathology at illness onset. For others, severe deficits in current cognitive functioning in the context of low premorbid IQ implies early limitations to cognitive capacity that may be consistent with neurodevelopmental insults and/or early and ongoing cognitive degeneration. 6, 7 Recently, Woodward and Heckers 9 reported that cognitively impaired patients with psychosis (bipolar disorder and schizophrenia) had reduced total brain volumes (TBV) as well as regionally specific fronto-temporal and subcortical gray matter loss relative to healthy individuals. However, cognitively impaired patients with compromised premorbid IQ showed evidence of brain hypoplasia in the form of reduced intracranial volume (ICV). Conversely, cognitively impaired patients with intact premorbid IQ, showed evidence of neural atrophy as demonstrated by reduced TBV but normal ICV. Czepielewski et al 13 largely replicated these findings in a smaller cohort of individuals diagnosed with schizophrenia only, demonstrating that patients with impaired current and premorbid cognitive functioning had reduced ICV and reductions in TBV, global cortical thickness, global gray matter and regional insula volumes. Patients with impaired current but intact premorbid cognitive impairments however, had only reduced TBV alongside reduced global cortical thickness and gray matter volume relative to controls. Weinberg et al 5 also recently reported extensive volumetric abnormalities in whole brain, total gray and white matter as well as in several cortical regions in a similarly categorized psychosis subgroup with average premorbid but below average current IQ. However, due to low statistical power these authors were unable to analyze a subgroup akin to that identified as having low premorbid and current intellectual function in previous studies.
Although cross-sectional in nature, these studies assumed that in the context of impaired current cognitive functioning, estimates of impaired premorbid IQ represented a "compromised" cognitive phenotype, while estimates of intact premorbid IQ represented a potentially "declining" cognitive phenotype. These studies therefore suggest that both neurodevelopmental and neurodegenerative processes may be of importance to understanding variability in brain-cognition relationships in schizophrenia. 14 However, all of these studies comprised small-medium sized samples for cognitive clustering, making it unclear whether the above brain structural findings are reproducible with larger samples. These studies also only examined global brain thickness and/or volumetric estimates, or regional brain volumes using voxel-wise or mean-regional volume approaches in relation to cognitive subgroups. Yet knowledge of brain-cognition relationships may further benefit from understandings of regional thickness differences between subgroups, as well as the unique contribution of surface area. The latter may have a neurodevelopmental basis as it has been shown to scale with the degree of cortical folding, a process occurring during mid-gestation and early postnatal brain development. [15] [16] [17] Both thickness and surface area are component measures of cortical volume thought to be negatively related, 18 genetically independent 19, 20 and have differing neurodevelopmental trajectories and relationships to IQ. 21, 22 It remains unclear however, whether thickness, surface area, and volume show similar or different relationships with cognitive variability in schizophrenia/schizoaffective disorder, particularly in the context of premorbid IQ; to date, there is a paucity of literature examining discrete brain structural indices in cognitive subgroups of psychosis with putatively differing cognitive courses. 5, 6, 8, 9, 13 In our recent study, 8 we used a data-driven approach to subgroup patients with schizophrenia and schizoaffective disorder into 3 groups based on estimated premorbid and current IQ. One group showed evidence of average premorbid and current cognitive performance, suggesting the presence of a "preserved" cognitive course unlikely to be impacted by neurodevelopmental or neurodegenerative abnormalities. A second group of patients with average premorbid IQ but current IQ below the control mean, showed evidence of a decline in cognitive functioning; these patients appeared to have a "deteriorated" cognitive course, with progressive degeneration assumed to originate at or after illness onset. Finally, a third group with low premorbid and low current IQ were considered to show evidence of a "compromised" cognitive course with abnormalities assumed to originate years before and continue after illness onset. Functional outcomes and symptomatology in the compromised subgroup were worse than that of preserved patients, suggesting group differentiation consistent with differences in cognitive profiles in and of themselves. These findings suggest that the pathways leading to cognitive outcomes in each of the subgroups may be different. However, the presence of other potentially distinguishing factors, including brain structure, was not examined.
Here, we aimed to build on work in this cohort by determining whether underlying structural brain abnormalities differentiate these cognitively derived subgroups. Our objectives were 2-fold; first, we aimed to replicate the findings by Woodward and Heckers 9 and Czepielewski et al. 13 in the current larger cohort. We predicted that smaller ICV would be apparent in the compromised subgroup as evidence of hypoplasia, whereas smaller TBV and normal ICV would be apparent in the deteriorated subgroup as evidence of atrophy. Second, we aimed to extend previous findings by examining whether the cognitive subgroups could be differentiated in terms of global and regional brain measures of volume, thickness and surface area. We predicted that both cognitively impaired subgroups would show brain structural abnormalities relative to controls, but that these would be more extensive in the compromised subgroup. Whether surface area differences would be evident only in the compromised patients with greater presumed neurodevelopmental influences remained exploratory.
Methods

Participants
Neuroimaging data from 220 patients with schizophrenia/schizoaffective disorder and 168 healthy controls was obtained from the Australian Schizophrenia Research Bank (ASRB). All participants provided informed consent for the analysis of their stored data. Study procedures were approved by the Melbourne Health Human Research Ethics Committee. Details of participant characterization are given in the supplementary material.
Cognitive subgroups were previously determined by applying clustering analysis to a larger dataset (n = 534) of patients from the ASRB (see Wells et al 8 for details). Briefly, tree and K-means clustering algorithms were used to determine the optimal number of clusters to retain from the data using standardized scores from the following tests; Wechsler Test of Adult Reading (WTAR), the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) immediate memory and attention index scores and the Wechsler Adult Intelligence Test-III LetterNumber Sequencing test. This strategy resulted in a 3-group solution, defined as putatively preserved, deteriorated and compromised subgroups of people with schizophrenia/schizoaffective disorder.
MRI Image Acquisition and Processing
T1-weighted (MPRAGE) structural scans were acquired using Siemens Avanto 1.5 tesla scanners. T1-weighted images comprised 176 sagittal slices/brain of 1 mm thickness without gap; field of view = 250 × 250 mm The same acquisition sequence was acquired at all ASRB sites. Image processing was conducted using the Freesurfer software package (version 5.1.0, http://surfer. nmr.mgh.harvard.edu/), comprising a volume and a surface-based stream. 23, 24 The former was used to extract mean volume estimates for ICV (estimate based on the talairach transform), TBV (brain segmentation volume without ventricles) and subcortical and cortical areas across the whole brain. The latter was used to extract cortical thickness and surface area measurements by reconstructing a 3-dimensional cortical surface model. Details of the preprocessing procedure are provided in the supplementary material.
Statistical Analysis
Demographic data were analyzed with one-way analyses of variance or chi-square tests using the Statistical Package for the Social Sciences (SPSS v22). Mean global and regional volume, thickness, and surface area values were extracted from Freesurfer and imported into SPSS, where the null hypothesis of equality across the 4 groups (controls, deteriorated, putatively preserved, and compromised) in each of these brain measures was tested using general linear models controlling for scanner site, gender, age, and ICV (for global volume except absolute TBV, regional volume, and surface area analyses only). Bivariate correlations were also conducted in the whole patient sample to ascertain relationships between brain measures and negative symptoms, given group differences in negative symptom severity. As no correlations survived false discovery rate (FDR; P < .05) correction for multiple testing, negative symptoms were not included as a covariate in the models comparing the 3 subgroups. The FDR was also used to correct for multiple comparisons for the following analyses separately: (1) global brain estimates: total left, right and whole cortex volume, thickness and surface area, total left and right cortical white matter volume, total cortical and subcortical gray matter volume, ICV, absolute TBV, and TBV adjusted for ICV (12 comparisons); (2) subcortical volume across the left and right putamen, pallidum, hippocampus, amygdala, thalamus, caudate, accumbens area, and cerebellum (16 comparisons); (3) regional cortical volume; (4) regional cortical thickness; and (5) regional cortical surface area. Analyses 3-5 were conducted on all 34 regions delineated by the Desikan-Killiany brain atlas; the left and right hemispheres were corrected separately using an FDR rate of P < .05 (34 comparisons per hemisphere per measure). Whenever the null hypothesis of equality across the 4 groups was rejected at a significance that survived FDR correction, pair-wise post hoc tests (6 comparisons) were performed and corrected using an FDR rate of 5% to assess where group differences lay. Effect sizes are reported as Cohen's d.
Results
The size of the subgroups in the ASRB subset of patients with available neuroimaging data were n = 73 patients putatively preserved; n = 100 deteriorated, n = 47 compromised. Demographic/clinical proportions and cognitive performance patterns on the clustering variables largely adhered to that seen in the larger sample (supplementary figure 1 ). There were no differences in antipsychotic medication use between subgroups, but there were more deteriorated patients taking anxiolytics and lithium than other subgroups. Table 1 presents the descriptive statistics for the sample. Table 2 presents comparisons of subcortical and cortical regions surviving FDR correction.
Global Brain Estimates
Subcortical Volume
Subgroups Vs Controls. All subgroups showed subcortical volumetric abnormalities, with statistically significant bilateral increases in the putamen and pallidum, and reductions in the hippocampus. Larger patient-control effect sizes for hippocampal reductions were evident in the compromised group (left d = −.86 and right d = −.77 vs all ds < −.58 for deteriorated and putatively preserved patients).
Subgroup Comparisons.
Compared to deteriorated patients, the compromised group had statistically significant reduced volumes of the hippocampus bilaterally (d = −.45 and d = −.47, respectively). Figure 2A shows the effect size maps for comparisons of cortical volume in regions surviving FDR correction. Table 2 quantifies the regions that significantly differed in cortical volume between groups.
Regional Cortical Volume
Subgroups Vs Controls. All subgroups showed statistically significant reductions in left inferior parietal cortex, right supramarginal gyrus and frontal pole and in the middle temporal gyrus and pars orbitalis bilaterally. Both cognitively impaired subgroups showed significantly smaller volumes of the right precentral gyrus and left lateral orbitofrontal cortex not seen in the putatively preserved patients. The compromised subgroup, however, was the only group to show significant volumetric reductions relative to controls bilaterally in the rostral middle frontal region and in the left temporal pole, left inferior temporal, superior frontal, and parahippocampal gyri and the right lateral occipital and superior temporal gyri, right lateral and medial orbitofrontal cortices and right pars triangularis. The putatively Preserved group showed specific significant reductions in the left superior temporal gyrus and right inferior temporal gyrus that were not seen in the other subgroups. Larger effect size differences were seen in the compromised Figure 2B shows the effect size maps for comparisons of cortical thickness for regions surviving FDR correction. Continued in the deteriorated patients, while reductions in the left isthmus of the cingulate was seen only in the putatively preserved patients and not in other groups. Both compromised and deteriorated patients had significantly thinner right inferior parietal cortex, left parahippocampal gyrus and left entorhinal cortex that was not evident in the putatively preserved group. The deteriorated and putatively preserved groups showed significant reductions in the left bank of the superior temporal sulcus and the right transverse temporal cortex not seen in the compromised patients. Greater effect size differences were seen in the compromised patients (range of d = 0.1 to −1. 
Regional Cortical Thickness and Surface Area
Discussion
In this study, we sought to determine the relationship between cognitive functioning and brain structure in schizophrenia/schizoaffective disorder, by examining whether structural abnormalities could differentiate 3 cognitive subgroups manifesting putatively differing cognitive trajectories of the disorder. 6,8 While reduced ICV in compromised patients was found, it was of a small magnitude, did not reach statistical significance and failed to support our hypothesis. Rather, we found evidence for reduced TBV (adjusting for ICV) in all subgroups compared with controls. It has been argued that ICV and TBV are markers of neurodevelopment and neurodegeneration, respectively. 9 This is due to the similar rate of increase in both measures prior to the teenage years, where, after reaching a critical point, there is a divergence in trajectory as represented by a decline in TBV in the context of relative stability in ICV over time. 25 Recent work 9, 13 shows that ICV reductions are present in psychosis patients with cognitive impairments presumed to originate prior to illness onset (indicating hypoplasia), whereas TBV reductions are evident in patients with cognitive impairments presumed to originate after illness onset (indicating atrophy). Our results did not clearly support these findings and our index of abnormal brain development (ICV) did not map onto our index of abnormal cognitive development (patients with premorbid IQ deficits). Instead, all of our cognitive subgroups appeared to be susceptible to some brain atrophy. Thus, hypoplasia, and subsequently, the notion of a static Represents qualitatively larger control-patient effect sizes in compromised patients.
Table 2.
Continued encephalopathy in compromised patients do not appear to be well-supported here. The discrepancy between our results and previous work is not likely to be explained by differences in the measures used to assess ICV and TBV, given that we re-ran our analyses using voxel-based morphometry generated values calculated with the same method as Woodward and Heckers, and the findings did not change (supplementary table 2 and Czepielewski et al 13 used composite scores from cognitive batteries tapping several broad cognitive domains to group patients into cognitively impaired or unimpaired samples based on whether premorbid IQ or the discrepancy between premorbid and current cognition was above or below the 10th percentile of the control distribution. In contrast, our subgroups were generated via a data-driven statistical clustering method based on performance on 3 separate memory and attention-indexing cognitive tests as well as premorbid IQ score, which resulted in 3 groups initially. As a result, the proportion of patients classified into the putatively preserved, deteriorated, and compromised subgroups in our cohort was less evenly distributed than that of the other samples, respectively, Woodward and Heckers reported distributions of n = 41, 52, 38 and Czepielewski et al reported distributions of n = 25, 31, 36. In contrast our distributions were n = 73, 100, and 47. While the proportion of putatively preserved patients was similar across studies (33% vs 31% and 27%) and therefore seemingly representative of the schizophrenia/schizoaffective population, our classification resulted in a lesser number of patients being classified as compromised (21% vs 29% and 39%). This suggests that our cohort was either a cognitively higher functioning cohort in general, or a cohort whose current cognitive impairments were not tapped to the same extent as the other studies.
Given the lack of statistical evidence for ICV reductions in any of the subgroups in our data, it is perhaps not surprising that there was also an absence of differences in surface area between groups. Surface area is influenced by the number of ontogenetic cortical columns orientated perpendicular to the brain's surface; which are established during early fetal development through the migration of neurons from the ventricular zone to their columnar location. 26, 27 Surface area therefore has early neurodevelopmental relevance, which does not appear to be of substantial influence on our data. Rather, maturational and/or adult neurodegenerative processes may be Represents qualitatively larger control-patient effect sizes in compromised patients. Table 3 .
Continued more significant contributors to the neural tissue underpinnings of all cognitive subgroups represented in our sample. Indeed, cortical thickness and volume in schizophrenia are known to be susceptible to accelerated aging and are associated with cognitive decline in neurodegenerative diseases. 22, [28] [29] [30] [31] In all of our subgroups, we saw global and regional volume and thickness abnormalities. While the volume abnormalities in the deteriorated group were less widespread than anticipated on the basis of a recently published study, 5 as expected, the pattern of both volume and thickness reductions was qualitatively and quantitatively most pronounced in compromised patients in neural tissue across all 4 lobes, particularly in the orbital, inferior (pars triangularis) and superior frontal, temporal (parahippocampus, temporal pole) and occipital regions (volume) as well as the left parahippocampus and rostral anterior cingulate (thickness). The compromised group also had smaller volumes and thickness in a number of regions not evident in the other groups; including in the left superior and middle frontal areas, left anterior and inferior temporal areas and right lateral medial and inferior frontal, occipital and superior temporal areas (volume), as well as the right parahippocampal and left supramarginal gyri (thickness).
The pattern of more prominent structural abnormalities in the subgroup with the most marked cognitive impairments-both currently and prior to illness onset, is consistent with the concept of schizophrenia as a progressive neurodevelopmental disorder. 32 It also fits with the concept and implications of variability in cognitive reserve; which describes the protective effect that higher premorbid intellect (reserve) has against age/illnessrelated degeneration of neural and cognitive processes. Proxies of cognitive reserve include performance on crystallized intelligence tests such as the WTAR, which tap into intellectual functions theoretically immune to age/illness-related decline. Lower performance on such tests, and thus, lower cognitive reserve, is thought to confer greater liability for cognitive and brain degeneration because the extent to which compensatory mechanisms (associated with pre-existing cognitive processes) can be enlisted to cope with age/illness-related pathology is reduced. 33, 34 In healthy adults, reduced cognitive reserve has been linked to exaggerated brain structural abnormalities, as well as reduced protection against the detrimental effects of these abnormalities on cognitive performance. 35 Since below-average premorbid IQ in the compromised group represents a marker of poor premorbid cognitive reserve capacity, it is not surprising that this group demonstrated the most pronounced brain abnormalities in several regions including the hippocampal complex; an area of reduced neurogenesis 36 and that is known to be at increased risk of illness and age-related decline and degeneration in healthy, psychiatric, and neurological disorder groups. [37] [38] [39] Critically, an indirect association between cognitive impairment and brain structural abnormalities was evident in our data, as both cognitively impaired patient groups did show specific volume and thickness reductions in circumscribed areas that were not seen in the putatively preserved patients. However, our preserved patients also had structural deficits in several other regions including in the superior frontal gyrus, superior inferior temporal gyri and inferior parietal lobule that were unexpected, since previous studies 5, 9, 13 reported reduced TBV and/or total gray and cortex volume in preserved patients but not sizeable localized gray matter volume reductions. The inconsistencies in results may relate to differences in the mean age of the preserved samples across studies; our putatively preserved group was somewhat older than the previous studies, and its illness duration was almost double that reported by Woodward and Heckers. Thus, a potentially greater impact of age and/or schizophrenia-related tissue decline in the putatively preserved patients in our data may partially explain the present findings. Given that age was significantly associated with brain structural deficits (most global and local thickness, surface area, and volume estimates) in the current study (data not shown), this remains a strong possibility.
Another important consideration relates to whether the preserved patients assessed here are in fact, truly "preserved." This may not necessarily be the case, since recent work shows that the association between intellectual functioning and the risk for schizophrenia is strongly predicted by the extent to which patients deviate from their familial cognitive aptitude, rather than their observed cognitive achievement. 40 Further, evidence indicating that neuropsychologically "normal" schizophrenia patients perform worse on cognitive tests than their unaffected monozygotic twins suggests that such patients deviate from what would be expected of their performance based upon genetic predisposition. 41 When framed in this context it is plausible that the structural brain abnormalities observed in the putatively preserved group here, represent the neural underpinnings of subtle cognitive impairments or a pathology-related cognitive decline that is not adequately captured by the current experimental design. Further work is required to explore this notion further. Nonetheless, it may explain the thinning and volume reductions evident in both cognitively impaired and unimpaired patients.
Our findings should be considered in the context of a number of limitations. Firstly, given limited medication data available in the ASRB (including dosing information), we were unable to adequately assess the effects of medication in the sample. However, previous work in this cohort has shown that antipsychotic medication is not correlated to cortical volumes. 31 Secondly, exclusion criteria in the ASRB precluded recruitment of patients with estimated premorbid IQs of less than 75. It is possible that even more pronounced differences would have been evident, including in ICV, had more severely premorbidly intellectually impaired patients been included in the analysis. Finally, distinctions between compromised and deteriorated patients are dependent on the assumption that differences between premorbid estimates and current cognition estimates represent actual cognitive decline over time. Despite evidence verifying the WTAR as a representative measure of premorbid IQ, 42 the cross-sectional nature of our study limits the extent to which this assumption can be established.
Despite this, our study is the largest of its kind to examine structural brain-cognition relationships through cognitive subgroups in schizophrenia/schizoaffective disorder, in the context of putative neurodevelopmental and neurodegenerative influences. Although our findings suggest that cortical volume and thickness reductions are present in all cognitive subgroups, the overall pattern of findings does appear to have some relevance in distinguishing them; with compromised patients demonstrating greater abnormalities in specific regions and potentially representing the manifestation of a greater impact of neurodegenerative processes. As no correlations were evident between negative symptom severity and any imaging measure, these brain structural differences are unlikely to be a simple reflection of differences in the severity of illness. Further work is needed to determine the extent to which these results replicate using similar cognitive batteries and in similar sized samples.
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Supplementary data are available at Schizophrenia Bulletin online. 
